Orbimed Advisors reported a 13.4% stake in Enliven Therapeutics ELVN · 7,918,163 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 13.4%
Last report: No earlier report
Shares held: 7,918,163 sh
Class: COMMON STOCK
Stock: Enliven Therapeutics ELVN
Holder: Orbimed Advisors
Event date: 25/06/16
Filed: 25/06/17

13.4% stake

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/17~25/07/16

Orbimed Advisors's other 5% stake reports

Orbimed Advisors
5% stakeElectra Therapeutics
5% stake
Electra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
Orbimed Advisors
5% stakeBraveheart Bio
5% stake
Braveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
Orbimed Advisors
5% stakeBraveheart Bio
5% stake
Braveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stake
BlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stake
Whitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14